Hall, Jacqueline Anne <br/><br/>
A risk-management approach for effective integration of biomarkers in clinical trials: perspectives of an NCI, NCRI, and EORTC working group.  [electronic resource] 

 -  The Lancet. Oncology  Apr 2014 
 - e184-93 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1474-5488 
<br/><br/><label>Standard No.: </label>10.1016/S1470-2045(13)70607-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biomarkers, Tumor--metabolism<br/>Checklist<br/>Clinical Trials as Topic--economics<br/>Consensus<br/>Europe<br/>Humans<br/>National Cancer Institute (U.S.)--economics<br/>Neoplasms--metabolism<br/>Patient Selection<br/>Research Design<br/>Research Support as Topic<br/>Risk Assessment<br/>Risk Factors<br/>Risk Management<br/>Treatment Outcome<br/>United States